Undiagnosed Cancer Cases in the US During the First 10 Months of the COVID-19 Pandemic.

ABSTRACT:

Importance

The COVID-19 pandemic disrupted the normal course of cancer screening and detection in the US. A nationwide analysis of the extent of this disruption using cancer registry data has not been conducted.

Objective

To assess the observed and expected cancer rate trends for March through December 2020 using data from all 50 US states and the District of Columbia.

Design, settings, and participants

This was a population-based cross-sectional analysis of cancer incidence trends using data on cases of invasive cancer diagnosis reported to the US Cancer Statistics from January 1, 2018, through December 31, 2020. Data analyses were performed from July 6 to 28, 2023.

Exposure(s)

Age, sex, race, urbanicity, and state-level response to the COVID-19 pandemic at th

SUBMITTER: Burus T 

PROVIDER: S-EPMC10884945 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature